Childhood Migraine Treatment Noninvasive Pulsed Radiofrequency vs Flunarizine

Damla Yürük

Status: Active, not recruiting

Conditions: Migraine Disease

Treatments: Drug: flunarizine; Device: Radiofrequency

Study type: Observational

Funder types: Other

Identifiers

NCT06753825

childhood migraine treatment

Details and patient eligibility

About

The aim of this observational study was to investigate the long-term effects of patients receiving interventional transcutaneous electrode-pulsed radiofrequency therapy versus calcium channel blockers for the treatment of childhood migraine pain. The main question to be answered was.

Which of the long-term effects of interventional transcutaneous pulsed radiofrequency versus calcium channel blockers for the treatment of childhood migraine pain is more effective? Participants who have started both treatments will answer questions about their headaches in an online survey for 3 months as part of their regular medical care.

Full description

There are two groups in the trial. One group will receive transcutaneous pulsed radiofrequency treatment for a total of 3 weekly sessions. The other group will receive 1x 5 mg flunarizine active ingredient. Both groups will consist of 30 patients. All patients will be followed from the start of treatment and will be assessed at month 1 and month 3 using the paediatric migraine disability index, headache diaries and visual pain scale.

Enrollment: 60 estimated patients

Sex: All

Ages: 7 to 17 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosed with migraine according to ICHD-3 Migraine criteria
• Being between the ages of 8-18
• Having 4 or more migraine attacks per month

Exclusion criteria

• Other primary or secondary headache diagnosis
• Patient could not be reached during follow-up

Trial design

60 participants in 2 patient groups

group pulsed radiofrequency

Description:

The group receiving pulsed radiofrequency therapy via transcutaneous electrodes receives 2 sessions of treatment, each lasting 8 minutes, once a week.

Treatment:

Device: Radiofrequency

group medical teratment

Description:

The group receiving 5 mg flunarizine treatment per day

Treatment:

Drug: flunarizine